Study on the efficacy and rotation pattern of Hydromorphone hydrochloride extended-release tablets in the treatment of chronic cancer-related pain

ZHAO Qiuling; CHEN Yanling; DONG Liangliang; CHEN Juan; HUANG Shengqiang; YANG Lin

doi:10.6039/j.issn.1001-0408.2026.12.12

您当前的位置：

首页 >

文章列表页 >

Study on the efficacy and rotation pattern of Hydromorphone hydrochloride extended-release tablets in the treatment of chronic cancer-related pain

更新时间：2026-06-26

- Study on the efficacy and rotation pattern of Hydromorphone hydrochloride extended-release tablets in the treatment of chronic cancer-related pain
- ZHONGGUO YAOFANG Vol. 37, Issue 12, Pages: 1590-1595(2026)
- 作者机构：
  
  福建医科大学肿瘤临床医学院，福建省肿瘤医院，福州　350014
- 作者简介：
- 基金信息：
- DOI：10.6039/j.issn.1001-0408.2026.12.12
  CLC： R969.3
- Received：23 March 2026，
  
  Revised：2026-05-11，
  
  Accepted：06 June 2026，
  
  Published：30 June 2026
- 稿件说明：
移动端阅览
赵秋玲,陈燕玲,董凉凉,等.盐酸氢吗啡酮缓释片治疗慢性癌痛的疗效及轮换模式研究[J].中国药房,2026,37(12):1590-1595.

ZHAO Qiuling,CHEN Yanling,DONG Liangliang,et al.Study on the efficacy and rotation pattern of Hydromorphone hydrochloride extended-release tablets in the treatment of chronic cancer-related pain[J].ZHONGGUO YAOFANG,2026,37(12):1590-1595.
赵秋玲,陈燕玲,董凉凉,等.盐酸氢吗啡酮缓释片治疗慢性癌痛的疗效及轮换模式研究[J].中国药房,2026,37(12):1590-1595. DOI： 10.6039/j.issn.1001-0408.2026.12.12.

ZHAO Qiuling,CHEN Yanling,DONG Liangliang,et al.Study on the efficacy and rotation pattern of Hydromorphone hydrochloride extended-release tablets in the treatment of chronic cancer-related pain[J].ZHONGGUO YAOFANG,2026,37(12):1590-1595. DOI： 10.6039/j.issn.1001-0408.2026.12.12.

摘要

目的

评估盐酸氢吗啡酮缓释片（HHERT）在真实世界中治疗慢性癌痛（CCRP）的疗效与安全性，并探讨其与其他阿片类药物（OOD）之间的轮换模式效果及轮换原因。

方法

回顾性收集2025年1－12月在福建省肿瘤医院接受阿片类药物治疗的142例CCRP患者资料，根据用药情况分为HHERT持续组和药物轮换治疗组，比较两组的疗效、不良反应发生情况。药物轮换治疗组进一步分为OOD-HHERT亚组（由OOD轮换为HHERT）和HHERT-OOD亚组（由HHERT轮换为OOD），比较两亚组的剂量换算系数是否符合指南推荐、轮换后疼痛缓解情况、轮换类型及轮换原因。

结果

142例CCRP患者中，107例患者疼痛缓解，总有效率为75.35%。治疗4周后，HHERT持续组与药物轮换治疗组疗效的差异有统计学意义（

＜0.05）。86例患者发生110例次不良反应，总不良反应发生率为77.46%，HHERT持续组与药物轮换治疗组不良反应发生率比较，差异均无统计学意义（

＞0.05）。99例发生阿片类药物轮换，总体轮换率为69.72%。HHERT-OOD亚组与OOD-HHERT亚组轮换后疼痛缓解率分别为74.36%和73.33%，疗效相当（

＞0.05）；31例（31.31%）患者剂量换算系数不符合指南推荐；两亚组轮换类型分布存在显著差异（

＜0.05）：HHERT-OOD亚组以给药途径变更为主，OOD-HHERT亚组以给药途径不变为主。HHERT-OOD

亚组因给药途径受限和药品供应短缺轮换的患者比例显著高于OOD-HHERT亚组（

＜0.05）；OOD-HHERT亚组因镇痛效果不佳轮换的患者比例显著高于HHERT-OOD亚组（

＜0.05）。

结论

在真实世界中，HHERT与阿片类药物轮换策略在CCRP治疗中具有较好的镇痛效果，轮换模式主要由镇痛效果不佳、给药途径受限等现实因素驱动。临床需进一步规范轮换剂量换算标准、把控轮换指征，优化癌痛个体化诊疗管理。

Abstract

OBJECTIVE

To evaluate the efficacy and safety of Hydromorphone hydrochloride extended-release tablets （HHERT） in the treatment of chronic cancer-related pain （CCRP） in real-world settings， and to explore the effectiveness and reasons for rotation patterns between HHERT and other opioid drugs （OOD）.

METHODS

Data were retrospectively collected from 142 CCRP patients receiving strong opioid therapy at Fujian Cancer Hospital from January to December 2025. Patients were divided into the continuous HHERT group and the drug rotation group based on medication status. The efficacy and incidence of adverse reactions were compared between the two groups. The drug rotation group was further subdivided into the OOD-HHERT group （rotated from OOD to HHERT） and the HHERT-OOD group （rotated from HHERT to OOD）. Dose conversion coefficients were compared with guideline recommendations， and pain relief status， rotation types and reasons for rotation were analyzed between the two subgroups.

RESULTS

In the 142 CCRP patients， 107 achieved pain relief， with an overall response rate of 75.35%. After 4 weeks of treatment， there was a statistically significant difference in efficacy between the continuous HHERT group and the drug rotation group （

＜0.05）. A total of 110 adverse reactions occurred in 86 patients， with an overall adverse reactions of 77.46%， there were no statistically significant differences between the continuos HHERT group and the drug rotation group in the incidence of drug adverse reactions （

＞0.05）. 99 experienced opioid rotation， with an overall rotation rate of

69.72%. The pain relief rates after rotation were 74.36% in the HHERT-OOD group and 73.33% in the OOD-HHERT group， indicating comparable efficacy （

＞0.05）. In 31 patients （31.31%）， the dose conversion coefficients did not conform to guideline recommendations. There was a significant difference in the distribution of rotation types between the two groups （

＜0.05）： the HHERT-OOD group was dominated by route of administration changes， while the OOD-HHERT group was dominated by unchanged route of administration. The proportion of rotations due to restricted route of administration and drug supply shortage was significantly higher in the HHERT-OOD group than that in the OOD-HHERT group （

＜0.05）； the proportion of rotations due to inadequate analgesic effect was significantly higher in the OOD-HHERT group than that in the HHERT-OOD group （

＜0.05）.

CONCLUSIONS

In real-world settings， both HHERT and opioid rotation strategies demonstrate favorable analgesic effects in the treatment of CCRP. Rotation patterns are primarily driven by practical factors such as inadequate analgesic effect and restricted route of administration. It is necessary to standardize dose conversion standards and indications for opioid rotation to improve individualized cancer pain management.

关键词

Keywords

references

中国医师协会疼痛科医师分会，中华医学会疼痛学分会，国家疼痛专业医疗质量控制中心，等 . 癌症相关性疼痛评估中国专家共识： 2023版 [J ] . 中国疼痛医学杂志， 2023 ， 29 （ 12 ）： 881 - 886 .

BENNETT M I ， KAASA S ， BARKE A ， et al . The IASP classification of chronic pain for ICD-11： chronic cancer-related pain [J ] . Pain ， 2019 ， 160 （ 1 ）： 38 - 44 .

吕岩，程建国，樊碧发，等 . ICD-11慢性疼痛分类中文编译版 [J ] . 中国疼痛医学杂志， 2018 ， 24 （ 11 ）： 801 - 805 .

SWARM R A ， YOUNGGWERTH J M ， AGNE J L ， et al . Adult cancer pain，version 2.2025，NCCN clinical practice guidelines in oncology [J ] . J Natl Compr Canc Netw ， 2025 ， 23 （ 7 ）： e250032 .

SNIJDERS R A H ， BROM L ， THEUNISSEN M ， et al . Update on prevalence of pain in patients with cancer 2022： a systematic literature review and meta-analysis [J ] . Cancers ， 2023 ， 15 （ 3 ）： 591 .

WANG W L ， HAO Y H ， PANG X ， et al . Cancer pain： molecular mechanisms and management [J ] . Mol Biomed ， 2025 ， 6 （ 1 ）： 45 .

中国医师协会疼痛科医师分会，国家卫生健康委能力建设和继续教育中心癌痛全程管理专家组 . 癌痛全程管理中国专家共识： 2025版 [J ] . 中国疼痛医学杂志， 2025 ， 31 （ 9 ）： 643 - 657 .

GONZÁLEZ-BARBOTEO J ， ALENTORN X G ， CALVO MANUEL F A ， et al . Effectiveness of opioid rotation in the control of cancer pain： the rotodol study [J ] . J Opioid Manag ， 2014 ， 10 （ 6 ）： 395 - 403 .

MERCADANTE S ， BRUERA E . Opioid switching in cancer pain： from the beginning to nowadays [J ] . Crit Rev Oncol Hematol ， 2016 ， 99 ： 241 - 248 .

中国抗癌协会癌痛整合治疗专业委员会 . 中国成人癌痛诊疗指南： 2025版 [J ] . 中华医学杂志， 2025 ， 105 （ 36 ）： 3148 - 3174 .

陈洁，焦现武，郝雪，等 . 盐酸羟考酮缓释片与硫酸吗啡缓释片在晚期癌痛患者中的应用比较 [J ] . 中国医药指南， 2025 ， 23 （ 15 ）： 55 - 57 .

DE IACO F ， MANNAIONI G ， SERRA S ， et al . Equianalgesia，opioid switch and opioid association in different clinical settings： a narrative review [J ] . Eur Rev Med Pharmacol Sci ， 2022 ， 26 （ 6 ）： 2000 - 2017 .

PAICE J A ， BOHLKE K ， BARTON D ， et al . Use of opioids for adults with pain from cancer or cancer treatment： ASCO guideline [J ] . J Clin Oncol ， 2023 ， 41 （ 4 ）： 914 - 930 .

CORLI O ， ROBERTO A ， CORSI N ， et al . Opioid swit-ching and variability in response in pain cancer patients [J ] . Support Care Cancer ， 2019 ， 27 （ 6 ）： 2321 - 2327 .

LEGAKIS L P ， WOO W ， CASSEL J B ， et al . Comparison of opioid rotation on pain，symptoms，and daily opioid dose in a supportive care clinic [J ] . Ann Palliat Med ， 2021 ， 10 （ 6 ）： 6336 - 6343 .

CASTEN M ， MILLER J L ， NEELY S B ， et al . Variability in opioid conversion calculators in critically ill children transitioned from fentanyl to hydromorphone [J ] . Am J Health Syst Pharm ， 2024 ， 81 （ 4 ）： 153 - 158 .

SCHUSTER M ， BAYER O ， HEID F ， et al . Opioid rotation in cancer pain treatment [J ] . Dtsch Arztebl Int ， 2018 ， 115 （ 9 ）： 135 - 142 .

DAVIS M P ， BOHLKE K ， DAVIES A . Opioid conversion in adults with cancer： MASCC-ASCO-AAHPM-HPNA-NICSO guideline clinical insights [J ] . J Pain Symptom Manag ， 2026 ， 71 （ 2 ）： e141 - e144 .

CUNNINGHAM E ， DIBIAGIO N ， O’ CONNELL F ， et al . Comparison of a novel methadone rotation method with other commonly used methods [J ] . BMJ Support Palliat Care ， 2026 ， 16 （ 2 ）： 490 - 493 .

蒋蒈耀，王丽娟，武蓓，等 . 医疗机构强阿片类药物资源的可及性和公平性分析 [J/OL ] . 中国医院药学杂志， 2026 ： 1 - 9 [ 2026-06-08 ] . https：//link.cnki.net/urlid/42.1204.R.2025-1218.1356.006 https://link.cnki.net/urlid/42.1204.R.2025-1218.1356.006 .

乔亚楠，蒋蒈耀，孟志强，等 . 门诊中重度疼痛患者强阿片类药物取药行为特征及影响因素研究 [J/OL ] . 中国药物依赖性杂志， 2026 ： 1 - 6 [ 2026-06-08 ] . https：//link.cnki.net/urlid/11.3920.R.20251212.1449.002 https://link.cnki.net/urlid/11.3920.R.20251212.1449.002 .

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

芬太尼透皮贴剂致胸壁肌肉强直继发呼吸困难的药学监护

ABCB1基因多态性与肾移植患者围手术期服用他克莫司相关不良反应的相关性

Mechanism of Yigan huayu formula in alleviating liver fibrosis based on proteomics

Design and management scheme practice of intelligent drug shelf positioning software based on the “five-level positioning” concept

Mechanism of Qingre antai decoction in improving pregnancy outcomes of threatened abortion rats with blood heat syndrome based on JAK2/STAT3 and PI3K/AKT dual signaling pathways

Related Author

LI Xinyu

ZHU Shenyin

QIU Feng

LIU Yu

XIE Peihua

CAI Yipeng

CHEN Quanjin

SONG Hongtao

Related Institution

No data

⁰